These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Statins and primary prevention of cardiovascular events. Donner-Banzhoff N; Sönnichsen A BMJ; 2008 Nov; 337():a2576. PubMed ID: 19010973 [No Abstract] [Full Text] [Related]
25. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention? Mora S; Ridker PM Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935 [TBL] [Abstract][Full Text] [Related]
26. Statins as cardioprotective agents. Piskur JR; Stone NJ Am J Manag Care; 2002 Jun; 8(9 Suppl):25-9. PubMed ID: 12099325 [No Abstract] [Full Text] [Related]
28. Gender-specific aspects of cardiovascular disease. Roberts BH Med Health R I; 2005 Oct; 88(10):339-41. PubMed ID: 16350933 [No Abstract] [Full Text] [Related]
29. [Statins in older patients: limits to prescription?]. Bosshard Taroni W; Büla C; Darioli R Rev Med Suisse; 2005 Nov; 1(39):2512-4, 2516-7. PubMed ID: 16323731 [TBL] [Abstract][Full Text] [Related]
30. Summaries of nursing care-related systematic reviews from the Cochrane library: statins for the primary prevention of cardiovascular disease. Li J; Zhou L J Cardiovasc Nurs; 2011; 26(4):288-9. PubMed ID: 21666420 [No Abstract] [Full Text] [Related]
31. Using statins to reduce cardiovascular risk after carotid endarterectomy. Floros G; Anagnostou V; Tsiga E; Ferenidou F; Papadimitriou D Evid Based Cardiovasc Med; 2006 Mar; 10(1):1-4. PubMed ID: 16530653 [No Abstract] [Full Text] [Related]
32. [The JUPITER study emphasizes primary prevention]. Olsson AG Lakartidningen; 2009 Jun 3-9; 106(23):1577. PubMed ID: 19583019 [No Abstract] [Full Text] [Related]
33. What do the statins tell us? LaRosa JC Am Heart J; 2002 Dec; 144(6 Suppl):S21-6. PubMed ID: 12486412 [TBL] [Abstract][Full Text] [Related]
35. A triumvirate of targets in the prevention and treatment paradigm for cardiovascular disease. Packard C Atheroscler Suppl; 2006 Apr; 7(1):21-9. PubMed ID: 16504600 [TBL] [Abstract][Full Text] [Related]
36. Primary prevention using statins: to be or not to be? Breimer LH; Mikhailidis DP Curr Med Res Opin; 2010 Nov; 26(11):2701-6. PubMed ID: 20954857 [No Abstract] [Full Text] [Related]
37. [HMG-CoA reductase inhibitors in prevention of cardiovascular diseases: new mechanisms, aspects and trials]. Wojakowski W; Gmiński J Przegl Lek; 2000; 57(5):291-5. PubMed ID: 11057120 [TBL] [Abstract][Full Text] [Related]
38. Genetic determinants of response to statins. Peters BJ; Klungel OH; de Boer A; Maitland-van der Zee AH Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):977-83. PubMed ID: 19673675 [TBL] [Abstract][Full Text] [Related]
39. Bad medicine: statins. Spence D BMJ; 2013 May; 346():f3566. PubMed ID: 23729321 [No Abstract] [Full Text] [Related]